PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 298.00
-2.00 (-0.67%)
At close: Mar 27, 2026
IDX:DGNS Market Cap
IDX:DGNS has a market cap or net worth of 372.5 billion as of March 27, 2026. Its market cap has increased by 72.25% in one year.
Market Cap
372.50B
Enterprise Value
445.77B
Revenue
157.99B
Ranking
n/a
PE Ratio
n/a
Stock Price
298.00
Market Cap Chart
Since January 15, 2021, IDX:DGNS's market cap has increased from 337.50B to 372.50B, an increase of 10.37%. That is a compound annual growth rate of 1.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 372.50B | 61.96% |
| Dec 30, 2025 | 230.00B | -5.64% |
| Dec 30, 2024 | 243.75B | -20.73% |
| Dec 29, 2023 | 307.50B | 0.82% |
| Dec 30, 2022 | 305.00B | -67.25% |
| Dec 30, 2021 | 931.25B | 175.93% |
| Jan 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 180.31T |
| PT Kalbe Farma Tbk. | 43.50T |
| PT Siloam International Hospitals Tbk | 35.72T |
| PT Mitra Keluarga Karyasehat Tbk | 30.04T |
| PT UBC Medical Indonesia Tbk | 600.40B |
| PT Itama Ranoraya Tbk | 575.99B |
| PT Diastika Biotekindo Tbk | 563.53B |
| PT Indofarma Tbk | 390.51B |